Buserelin
Get a Quick Quote Now
Select Packaging
Product Description
Product
Buserelin
CAS
57982-77-1
Formula
C15H14ClN3O4S
Synonym
BUSERELIN, 57982-77-1, PXW8U3YXDV, ICI 123215, HOE 766, Etilamide, (Des-Gly10,D-Ser(tBu)6,Pro-NHEt9)-LHRH, Buserelin (INN), BUSERELIN [INN], Buserelina, Busereline, Buserelinum, Buserelin [INN:BAN], UNII-PXW8U3YXDV, Busereline [INN-French], Buserelinum [INN-Latin], Buserelina [INN-Spanish], Metrelef, CCRIS 2657, HOE 766A, Tiloryth (TN), EINECS 261-061-9, D-Ser-(TBu)(sup 6)-LHRH-ethylamide, BUSERELIN [MI], (D-Ser(tbu)(sup 6)-EA(sup 10))-LHRH, BUSERELIN [MART.], BUSERELIN [WHO-DD], SCHEMBL13354, S 746766, GTPL3860, BUSERELIN [EP MONOGRAPH], Buserelin for NMR identification, CHEMBL2110824, D-Ser(tbu(sup 6))-LH-RH-(1-9)-nonapeptide ethylamide, SCHEMBL19409318, SCHEMBL19459955, Buserelin for peak identification, CHEBI:135907, DTXSID301024155, (D-Ser(Bu(sup t)(sup 6)))-LH-RH(1-9)nonapeptide-ethylamide, AKOS015994645, AKOS030213242, HS-2005, NCGC00181295-01, D07259, A831694, Q414745, W-105422, (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)-1-pyrrolidinyl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hy, (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-[bis(azanyl)methylideneamino]-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxidanylidene-pentan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxi, 5-oxo-l-prolyl-l-histidyl-l-tryptophyl-l-seryl-l-tyrosyl-o-tert-butyl-d-seryl-l-leucyl-l-arginyl-n-ethyl-l-prolinamide
Typical Product Specifications
Assay/Purity
Typically NLT 98%
Notes
Buserelin is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
Class
Industry
Buserelin
Product Description
Product
Buserelin
CAS
57982-77-1
Formula
C15H14ClN3O4S
Synonym
BUSERELIN, 57982-77-1, PXW8U3YXDV, ICI 123215, HOE 766, Etilamide, (Des-Gly10,D-Ser(tBu)6,Pro-NHEt9)-LHRH, Buserelin (INN), BUSERELIN [INN], Buserelina, Busereline, Buserelinum, Buserelin [INN:BAN], UNII-PXW8U3YXDV, Busereline [INN-French], Buserelinum [INN-Latin], Buserelina [INN-Spanish], Metrelef, CCRIS 2657, HOE 766A, Tiloryth (TN), EINECS 261-061-9, D-Ser-(TBu)(sup 6)-LHRH-ethylamide, BUSERELIN [MI], (D-Ser(tbu)(sup 6)-EA(sup 10))-LHRH, BUSERELIN [MART.], BUSERELIN [WHO-DD], SCHEMBL13354, S 746766, GTPL3860, BUSERELIN [EP MONOGRAPH], Buserelin for NMR identification, CHEMBL2110824, D-Ser(tbu(sup 6))-LH-RH-(1-9)-nonapeptide ethylamide, SCHEMBL19409318, SCHEMBL19459955, Buserelin for peak identification, CHEBI:135907, DTXSID301024155, (D-Ser(Bu(sup t)(sup 6)))-LH-RH(1-9)nonapeptide-ethylamide, AKOS015994645, AKOS030213242, HS-2005, NCGC00181295-01, D07259, A831694, Q414745, W-105422, (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)-1-pyrrolidinyl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hy, (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-[bis(azanyl)methylideneamino]-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxidanylidene-pentan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxi, 5-oxo-l-prolyl-l-histidyl-l-tryptophyl-l-seryl-l-tyrosyl-o-tert-butyl-d-seryl-l-leucyl-l-arginyl-n-ethyl-l-prolinamide
Typical Product Specifications
Assay/Purity
Typically NLT 98%
Notes
Buserelin is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
Class
Industry
